News Details
24/06/2026 15:05
Bliss GVS Pharma - Disclosure under SEBI Takeover Regulations
Bliss GVS Pharma Limited has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.